Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Bhagiradha Chemicals & Industries Ltd

BHAGCHEM
NSE
268.22
0.15%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Bhagiradha Chemicals & Industries Ltd

BHAGCHEM
NSE
268.22
0.15%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
3,478Cr
Close
Close Price
268.22
Industry
Industry
Pesticides/Agrochemicals
PE
Price To Earnings
265.56
PS
Price To Sales
6.95
Revenue
Revenue
500Cr
Rev Gr TTM
Revenue Growth TTM
16.63%
PAT Gr TTM
PAT Growth TTM
-39.80%
Peer Comparison
How does BHAGCHEM stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
BHAGCHEM
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
12310012274111111104103123124140114
Growth YoY
Revenue Growth YoY%
-11.0-17.8-7.4-41.0-9.211.4-15.038.110.211.135.110.9
Expenses
ExpensesCr
104931096697999494117115125100
Operating Profit
Operating ProfitCr
1871381412109691514
OPM
OPM%
14.97.111.011.112.710.89.48.95.07.310.812.0
Other Income
Other IncomeCr
000112321101
Interest Expense
Interest ExpenseCr
222221222343
Depreciation
DepreciationCr
333333344445
PBT
PBTCr
143951110862386
Tax
TaxCr
513134223-122
PAT
PATCr
92637654-1465
Growth YoY
PAT Growth YoY%
-13.7-83.5-53.1-71.5-23.1189.8-4.98.1-112.2-30.31.128.7
NPM
NPM%
7.72.04.74.56.55.15.23.5-0.73.23.94.0
EPS
EPS
0.90.20.60.30.10.50.40.3-0.10.30.40.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
246318436502408440500
Growth
Revenue Growth%
29.437.015.3-18.88.113.6
Expenses
ExpensesCr
229271367425365404457
Operating Profit
Operating ProfitCr
17476877433744
OPM
OPM%
6.914.815.715.410.58.48.8
Other Income
Other IncomeCr
4211393
Interest Expense
Interest ExpenseCr
58958712
Depreciation
DepreciationCr
78910111416
PBT
PBTCr
9325164272519
Tax
TaxCr
2916199115
PAT
PATCr
7233645181413
Growth
PAT Growth%
258.453.326.3-59.6-23.9-4.6
NPM
NPM%
2.67.38.29.04.53.12.6
EPS
EPS
0.72.53.84.40.21.11.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
88810101313
Reserves
ReservesCr
124147182303318669677
Current Liabilities
Current LiabilitiesCr
8395133101126195207
Non Current Liabilities
Non Current LiabilitiesCr
102219333756143
Total Liabilities
Total LiabilitiesCr
2252733424475769331,040
Current Assets
Current AssetsCr
79114174228280375392
Non Current Assets
Non Current AssetsCr
147159168219296558648
Total Assets
Total AssetsCr
2252733424475769331,040

Cash Flow

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
48471434-53
Investing Cash Flow
Investing Cash FlowCr
-39-21-17-60-116-200
Financing Cash Flow
Financing Cash FlowCr
-915124688272
Net Cash Flow
Net Cash FlowCr
0-221719
Free Cash Flow
Free Cash FlowCr
9-17-10-46-45-302
CFO To PAT
CFO To PAT%
740.115.318.530.8188.2-381.0
CFO To EBITDA
CFO To EBITDA%
284.57.69.718.079.9-142.9

Ratios

Consolidated
Standalone
Financial YearMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2094208441,2451,6763,605
Price To Earnings
Price To Earnings
32.118.123.727.692.0259.8
Price To Sales
Price To Sales
0.81.31.92.54.18.2
Price To Book
Price To Book
1.62.74.54.05.15.3
EV To EBITDA
EV To EBITDA
14.410.313.516.740.299.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
35.036.836.537.639.536.9
OPM
OPM%
6.914.815.715.410.58.4
NPM
NPM%
2.67.38.29.04.53.1
ROCE
ROCE%
8.418.522.318.98.94.2
ROE
ROE%
4.915.018.814.45.52.0
ROA
ROA%
2.98.510.410.13.21.5
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Bhagiradha Chemicals & Industries Limited (BCIL) is a leading Indian agrochemical manufacturer listed on the BSE (531719) and NSE (BHAGCHEM), headquartered in Hyderabad, Telangana. Founded in **1993** by the late **Sri Singavarapu Koteswara Rao**, a former scientist at the Indian Institute of Chemical Technology (IICT), Hyderabad, BCIL has evolved into an R&D-driven, vertically integrated player in the global agrochemical supply chain. The company specializes in the manufacture of **technical-grade pesticides** — including insecticides, herbicides, fungicides, and specialty intermediates — serving regulated markets across more than 25 countries. --- ### **Core Business & Strategic Focus** BCIL operates as a science-led, innovation-focused enterprise with key competitive advantages in: - **Deep backward integration** (up to N-7/N-9 stages) - **In-house R&D for non-infringing synthesis processes** - **Rapid product development and scale-up capabilities** - **Regulatory compliance for export to high-barrier markets** - **Cost efficiency and competitive pricing without compromising quality** The company aims to deliver sustainable growth by capitalizing on off-patent molecules, expanding manufacturing capacity, and strengthening its presence in regulated global markets. --- ### **Operational Profile** | **Parameter** | **Details** | |--------------|-----------| | **Established** | 1993 | | **Founders** | Late S. Koteswara Rao & S. Dodda Sadasivudu | | **Listed On** | BSE (1996), NSE | | **Headquarters** | Hyderabad, Telangana | | **Managing Director** | Mr. S. Chandrasekhar (former R&D head) | | **Global Presence** | Exports to >25 countries | | **Employee Strength** | ~700 (direct and indirect) | #### **Manufacturing Facilities** 1. **Ongole, Andhra Pradesh** - Installed capacity: **3,250 MTPA** - 3 production blocks, 4–5 process lines - Utilization: ~80% - Products: 7–10 AI/intermediates/formulations annually - Features: Zero Liquid Discharge (ZLD) ETP, modernized utilities, on-site R&D & pilot plant - Key products: Chlorpyriphos, Imidacloprid, Azoxystrobin, Fipronil, Thiamethoxam 2. **Karnataka Facility (Under Development)** - Subsidiary: **Bheema Fine Chemicals Private Limited** - Planned Capacity: **9,002 MTPA** - Status: Environmental clearance secured; Phase I operational from 2024, full production expected Q2 FY25–26 - Advantages: Modular design, on-site TSDF, assured water (KIADB), proximity to skilled labor, solar-powered operations #### **R&D Capabilities** - Government-approved **DSIR-recognized R&D center** located at Ongole plant. - **Over 60 chemists**, 8 synthesis labs, pilot & semi-commercial plants. - Strategic collaborations with **MNCs from the US, Japan, and Israel**, and research tie-up with **IICT, Hyderabad**. - Focus areas: Non-infringing process development for off-patent molecules, cost optimization, IP generation. - **28+ products commercialized**, all developed in-house; pipeline of 3–4 new molecules/year. - **Two Indian patents granted**: - High-purity trifluoromethyl sulfinyl chloride synthesis (hypervalent iodine catalyst) - Process for [1,4,5]-oxadiazepane salts #### **Financial Performance** - **Revenue FY24**: ₹408 crores - **Crossed ₹500 crores in turnover during CY2023** - Strong volume recovery from **H2 FY25**, with **double-digit growth in H1 FY26** despite pricing pressures - Target: **₹2,500 crores+ revenue by FY31–32** #### **Sustainability Initiatives** - Commissioned a **4 MW solar power plant** at Ongole facility, reducing energy costs and carbon footprint. - Investment of **₹70–100 crore in solar projects** under capex plan. - Zero Liquid Discharge (ZLD), advanced ETP (Reverse Osmosis, Multiple Effect Evaporators), green belt (>60% of site area). --- ### **Market Position & Competitive Edge** - **Domestic Market Share**: ~27% in key agrochemical segments - **Global Market Share**: ~6% - One of the few Indian manufacturers with deep backward integration in complex molecules like **Azoxystrobin, Fipronil, and Trifloxystrobin**. - High gross material margins due to proprietary processes and integrated supply chain. - Positioned as a **trusted supplier in regulated markets**, supported by IPR ownership and compliance with global standards. --- ### **Recent Milestones (2024–2025)** - Commercial launch of **Trifloxystrobin**, a top-tier fungicide effective across key crops (rice, grapes, mango, tomato). - Introduction of **Chlorantraniliprole**, a low-toxicity, IPM-compatible diamide insecticide. - Commencement of operations at **Bheema Fine Chemicals (March 2024)**. - Expansion of **export market reach to Bangladesh and Africa**. - Implementation of **ERP systems** to enhance decision-making and operational efficiency. - Strengthened **registration department** to fast-track approvals in domestic and international markets. --- ### **Risks & Mitigation** | **Risk** | **Response Strategy** | |--------|----------------------| | Raw material price volatility | Enhanced backward integration, inventory optimization | | Chinese import competition | Cost-efficient, locally produced alternatives; "China +1" alignment | | Regulatory delays | Strengthened registration team; parallel approval filings | | Single-site dependence (AP plant) | Risk mitigated by Karnataka greenfield project (multi-product, flexible facility) | | Geopolitical & trade shifts | Diversified geography and customer portfolio |